These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 23378010

  • 1. Evaluation of the QMS® Teicoplanin Immunoassay (ThermoFisher Scientific) on Cobas® 8000 System (Roche Diagnostics) and comparison to fluorescence polarization immunoassay for the determination of teicoplanin concentrations in human plasma.
    Dailly E, Fraissinet F, Deslandes G, Bouquié R, Jolliet P.
    J Clin Lab Anal; 2013 Mar; 27(2):96-8. PubMed ID: 23378010
    [Abstract] [Full Text] [Related]

  • 2. Performance of a fluorescence polarization immunoassay for teicoplanin in serum.
    Mastin SH, Buck RL, Mueggler PA.
    Diagn Microbiol Infect Dis; 1993 Jan; 16(1):17-24. PubMed ID: 8425374
    [Abstract] [Full Text] [Related]

  • 3. Validation of a free phenytoin assay on Cobas c501 analyzer using calibrators from Cobas Integra free phenytoin assay by comparing its performance with fluorescence polarization immunoassay for free phenytoin on the TDx analyzer.
    Dasgupta A, Davis B, Chow L.
    J Clin Lab Anal; 2013 Jan; 27(1):1-4. PubMed ID: 23325740
    [Abstract] [Full Text] [Related]

  • 4. Assay of teicoplanin in serum: comparison of high-performance liquid chromatography and fluorescence polarization immunoassay.
    McCann SJ, White LO, Keevil B.
    J Antimicrob Chemother; 2002 Jul; 50(1):107-10. PubMed ID: 12096014
    [Abstract] [Full Text] [Related]

  • 5. Analysis using fluorescence polarization immunoassay for unbound teicoplanin concentration in serum.
    Urakami T, Maiguma T, Kaji H, Kondo S, Teshima D.
    J Clin Pharm Ther; 2008 Aug; 33(4):357-63. PubMed ID: 18613853
    [Abstract] [Full Text] [Related]

  • 6. Quantification of teicoplanin in plasma by LC-MS with online sample clean-up and comparison with QMS assay.
    Mueller DM, von Eckardstein A, Saleh L.
    Clin Chem Lab Med; 2014 Jun; 52(6):879-87. PubMed ID: 24445242
    [Abstract] [Full Text] [Related]

  • 7. Clinical evaluation of teicoplanin fluorescence polarization immunoassay.
    Rybak MJ, Bailey EM, Reddy VN.
    Antimicrob Agents Chemother; 1991 Aug; 35(8):1586-90. PubMed ID: 1834014
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. New modified fluorescence polarization immunoassay does not falsely elevate vancomycin concentrations in patients with end-stage renal disease.
    Smith PF, Petros WP, Soucie MP, Copeland KR.
    Ther Drug Monit; 1998 Apr; 20(2):231-5. PubMed ID: 9558140
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of a Methotrexate Chemiluminescent Microparticle Immunoassay:  Comparison to Fluorescence Polarization Immunoassay and Liquid Chromatography-Tandem Mass Spectrometry.
    Bouquié R, Grégoire M, Hernando H, Azoulay C, Dailly E, Monteil-Ganière C, Pineau A, Deslandes G, Jolliet P.
    Am J Clin Pathol; 2016 Jul; 146(1):119-24. PubMed ID: 27357291
    [Abstract] [Full Text] [Related]

  • 11. Determination of blood sirolimus concentrations in liver and kidney transplant recipients using the Innofluor fluorescence polarization immunoassay: comparison with the microparticle enzyme immunoassay and high-performance liquid chromatography-ultraviolet method.
    Bouzas L, Hermida J, Tutor JC.
    Ups J Med Sci; 2009 Jul; 114(1):55-61. PubMed ID: 19242874
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Establishment of norvancomycin fluorescence polarization immunoassay for therapeutic drug monitoring.
    Wu XJ, Zhang J, Yu JC, Cao GY, Shi YG, Zhang YY, Wang MG.
    J Antibiot (Tokyo); 2012 Jan; 65(1):35-9. PubMed ID: 22045420
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of the Novel Methotrexate Architect Chemiluminescent Immunoassay: Clinical Impact on Pharmacokinetic Monitoring.
    Aumente MD, López-Santamaría J, Donoso-Rengifo MC, Reyes-Torres I, Montejano Hervás P.
    Ther Drug Monit; 2017 Oct; 39(5):492-498. PubMed ID: 28682926
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The quality of clinical serum teicoplanin assays: an experimental European EQA distribution.
    White LO, McMullin C, Davis AJ, MacGowan AP, Harding I, Reeves DS.
    J Antimicrob Chemother; 1996 Oct; 38(4):701-6. PubMed ID: 8937964
    [Abstract] [Full Text] [Related]

  • 18. Comparison of a new serum topiramate immunoassay to fluorescence polarization immunoassay.
    Snozek CL, Rollins LA, Peterson PW, Langman LJ.
    Ther Drug Monit; 2010 Feb; 32(1):107-11. PubMed ID: 20010458
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.